FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mike Warwick

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Drug Interactions

Phenomena

Metabolic Clearance Rate

Co-author Network

Publications

TOP 3
Caroline K Hull; Paul D Martin; Mike J Warwick; Elizabeth Thomas
Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection.
Steven G Simonson; Paul D Martin; Mike J Warwick; Patrick D Mitchell; Dennis W Schneck
The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptive.
Paul D Martin; Mike J Warwick; Aaron L Dane; Steve J Hill; Petrina B Giles; Paul J Phillips; Eva Lenz
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mike Warwick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Caroline K Hull; Paul D Martin; Mike J Warwick; Elizabeth Thomas
Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection.
Journal of pharmaceutical and biomedical analysis 2004;35(3):609-14.
2004: Steven G Simonson; Paul D Martin; Mike J Warwick; Patrick D Mitchell; Dennis W Schneck
The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptive.
British journal of clinical pharmacology 2004;57(3):279-86.
2003: Paul D Martin; Mike J Warwick; Aaron L Dane; Steve J Hill; Petrina B Giles; Paul J Phillips; Eva Lenz
Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers.
Clinical therapeutics 2003;25(11):2822-35.
2003: Paul D Martin; Mike J Warwick; Aaron L Dane; Charlie Brindley; Tracy Short
Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
Clinical therapeutics 2003;25(10):2553-63.
2003: Paul D Martin; Mike J Warwick; Aaron L Dane; Mireille V Cantarini
A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers.
Clinical therapeutics 2003;25(8):2215-24.
2003: Kelvin J Cooper; Paul D Martin; Aaron L Dane; Mike J Warwick; Ali Raza; Dennis W Schneck
The effect of erythromycin on the pharmacokinetics of rosuvastatin.
European journal of clinical pharmacology 2003;59(1):51-6.
2003: Kelvin J Cooper; Paul D Martin; Aaron L Dane; Mike J Warwick; Dennis W Schneck; Mireille V Cantarini
Effect of itraconazole on the pharmacokinetics of rosuvastatin.
Clinical pharmacology and therapeutics 2003;73(4):322-9.
2003: Paul D Martin; Aaron L Dane; Dennis W Schneck; Mike J Warwick
An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers.
Clinical therapeutics 2003;25(2):459-71.
2003: Steven G Simonson; Paul D Martin; P Mitchell; Dennis W Schneck; Kenneth C Lasseter; Mike J Warwick
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment.
European journal of clinical pharmacology 2003;58(10):669-75.
2003: Kelvin J Cooper; Paul D Martin; Aaron L Dane; Mike J Warwick; Ali Raza; Dennis W Schneck
Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects.
British journal of clinical pharmacology 2003;55(1):94-9.
2002: Paul D Martin; John Kemp; Aaron L Dane; Mike J Warwick; Dennis W Schneck
No effect of rosuvastatin on the pharmacokinetics of digoxin in healthy volunteers.
Journal of clinical pharmacology 2002;42(12):1352-7.
2002: Kelvin J Cooper; Paul D Martin; Aaron L Dane; Mike J Warwick; Dennis W Schneck; Mireille V Cantarini
The effect of fluconazole on the pharmacokinetics of rosuvastatin.
European journal of clinical pharmacology 2002;58(8):527-31.
2002: Paul D Martin; Aaron L Dane; Olise M Nwose; Dennis W Schneck; Mike J Warwick
No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor.
Journal of clinical pharmacology 2002;42(10):1116-21.
2001: F McTaggart; L Buckett; R Davidson; Geoffrey A Holdgate; A McCormick; Dennis W Schneck; G Smith; Mike J Warwick
Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
The American journal of cardiology 2001;87(5A):28B-32B.